Healthcare Business Insights, Part of Clarivate

CPA Global

Dialog Solutions (now Clarivate)

Markpro

Clarivate for Life Sciences & Healthcare

Clarivate for Intellectual Property

Derwent_UI/UX_early_look

Clarivate is a leading global information services provider. We connect people and organizations to intelligence they can trust to transform their perspective, their work and our world. Our subscription- and technology-based solutions are coupled with deep domain expertise and cover the areas of Academia & Government, Life Sciences & Healthcare and Intellectual Property. For more information, please visit clarivate.com.​ 

Clarivate

Ed Guntin, President and Managing Partner of Guntin & Gust, recently shared how FoundationIP has been a game-changer for his firm. Learn how this solution has forged client relationships and made his renowned Chicago-based IP law firm as trusted Clarivate partner: https://lnkd.in/gtPpskS6

#ThinkForward #Customerstories #IP

We kicked off 2024 by bringing our colleagues around the world together and inspire a Think forward mindset. We look forward to another year leading the innovation lifecycle, sharing insights from our experts and making a lasting impact on the world.

#TeamBuilding #ThinkForward

"New modalities, underpinned by scientific breakthroughs in the past decade, are achieving clinical successes and providing treatments for patients with previously unmet medical needs." - Henry Levy, President, Clarivate for Life Sciences & Healthcare

Explore the 13 new therapeutics featured on Drugs to Watch 2024 report with standout commercial and clinical potential on our blog: https://lnkd.in/gVzE4hEc

#ThinkForward #DrugstoWatch2024 #Healthcare

Explore the world of innovation and uncover awe-inspiring stories on Ideas to Innovation - Season 3. Each episode is packed with creative problem-solving strategies that lead to real-world applications on groundbreaking ideas. Hear from industry experts as they delve into their first-hand experiences, sharing their valuable insights and unique perspectives. Listen today: https://lnkd.in/gWE4duzT

Apple Podcasts: https://lnkd.in/gABCFQX
Spotify: https://lnkd.in/gukez4Ra

#ThinkForward #Innovation #Podcasts

Clarivate releases the 11th annual Drugs to Watch report identifying thirteen potential blockbuster drugs and game changers, including therapeutic advancements for breast cancer, RSV, sickle cell disease and Crohn's. 
 
"Leveraging deep industry expertise and comprehensive therapeutic area differentiated data, this year’s Drugs to Watch report identifies innovative medicines based on recent scientific breakthroughs poised to have a transformational impact on patient outcomes.” - Mike Ward, Global Head of Thought Leadership, Clarivate for Life Sciences & Healthcare
 
Read forecasting insights in the full report: https://lnkd.in/grheDDiA
  
#ThinkForward #DrugstoWatch #Healthcare

Web of Science MyRA

Cortellis Regulatory Alerts

MyItinerary by ScholarOne

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

DNSSEC

Google Maps

Content Delivery Network

Font Awesome

Chief Operations Officer, Technology

Anyu Gao

Senior Director, Associate General Counsel

Cara Tamker

Chief Information Security Officer

Christian Wagner

Chief Information Officer

Frank Paleno

Marketing and Product

Irina Fays

Assistant General Counsel, Director in Corporate Legal Services

Janet Driver

VP & Deputy General Counsel

Janice Read

Chief Legal Officer & General Counsel

Jas Chahal

President, Science Group

Jeff Scanlon

Legal

Julie Gillis

Rahul verma

Charles Neral

Jane Okun Bomba

Steve Hartman

General Counsel and Global Head of Business Development

Jerre Stead

Executive Chairman and Chief Executive Officer

Armughan Rafat

Chief Data Officer

Randy Harvey

Chief Technology Officer

Shauna Osborne

Vice President, Commercial Performance and Operations Strategy

Sandra Mau

Vice President - Government Solutions

Ketan Patel

Vice President, Cortellis Product Platform

Mike Ward

Global Head of Life Sciences & Healthcare Thought Leadership

Greater Philadelphia Area Acquired Companies With More Than $500 in Revenue

Pennsylvania Acquired Companies With More Than $10M in Revenue

Pennsylvania Acquired Companies With More Than $100M in Revenue

Great Lakes Companies With More Than 10 Employees (Top 10K)

Clarivate Analytics accelerates the pace of innovation by providing trusted insights and analytics to customers around the world, enabling them to discover, protect, and commercialize new ideas faster. The company provides critical data, information, workflow solutions, and deep domain expertise to innovators. It is a trusted global partner to customers,  such as universities, nonprofits, funding organizations, publishers, corporations, government organizations, and law firms.

Clarivate Analytics focuses on scientific and academic research, patent analytics and regulatory standards, pharmaceutical and biotech intelligence, trademark protection, domain brand protection, and intellectual property management services.

Elliott Investment Management

Post-IPO Equity - Clarivate Analytics

Convertible Note - Clarivate Analytics

Funding Round - Clarivate Analytics

Series A - Clarivate Analytics

Philadelphia

Pennsylvania

United States

North America

Clarivate Analytics

Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence

Clarivate Acquires Rowan TELS to Enhance Support for Patent Practitioners

Clarivate Launches IP Collaboration Hub

Clarivate Reveals World's Leading and Trusted Journals with the 2024 Journal Citation Reports

Clarivate Reveals World's Leading and Trusted Journals with the 2024 Journal Citation Reports USA - English

Clarivate Launches Research Horizon Navigator to Pinpoint Future Breakthrough Areas USA - English

Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health (SDoH) Attributes from ...

Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis USA - English

Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024

Provides insights from healthcare data products for research, investigating patient populations and clinical outcomes.

Offers formulary data and tools for analyzing brand positioning against competitors in the market.

Supports life science companies in identifying and assisting patients at the point of care and dispensing.

Consulting services for biopharmaceutical and MedTech clients, focusing on market assessments, product positioning, and launch strategies.

Technical consulting across the product journey, focusing on maximizing evidence value for successful access and reimbursement strategies.

Custom technology solutions and consulting, including systems integration, data informatics, and custom solution development.

China

Asia

India

United Kingdom

Europe

Brazil

South America

HTML5

Google Fonts

Oracle Eloqua

Microsoft Outlook

.NET 4.5

Google Drive

jQuery

Wordpress

Fastly

GlobalSign

Clarivate Analytics owns SCIENCEWATCH

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

news impact assignment basic	general
public peers	general
news daily refresh	general	Aug 6, 2024 8:40 PM	a8ea107e
news processing daily refresh	general	May 21, 2024 2:57 AM	5818a0ae
news impact assignment daily	general	May 21, 2024 5:05 PM	88112c92
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	3283b8ad
crunchbase profile	general	Nov 27, 2024 1:21 PM	4d61fdf8
li profile	general	Feb 6, 2024 12:37 AM	95e06d63
translate crunchbase fundingrounds	general	Nov 27, 2024 2:59 PM	419edfdf
peers	general	Feb 6, 2024 12:37 AM	8bf36eef
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:CLARIVATE

Clarivate

Last Close

5.14

22/11 21:00

Market Cap

3.97B

Beta: -

Volume Today

5.30M

Avg: -